Tazofelone structure
|
Common Name | Tazofelone | ||
|---|---|---|---|---|
| CAS Number | 107902-67-0 | Molecular Weight | 321.47700 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H27NO2S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TazofeloneTazofelone (LY 213829) is a cyclooxygenase-II (COX-II) inhibitor. Tazofelone transform into sulfoxide and quinol metabolites is primarily mediated by CYP3A. Tazofelone can be used for the research of inflammatory bowel disease[1][2]. |
| Name | tazofelone |
|---|---|
| Synonym | More Synonyms |
| Description | Tazofelone (LY 213829) is a cyclooxygenase-II (COX-II) inhibitor. Tazofelone transform into sulfoxide and quinol metabolites is primarily mediated by CYP3A. Tazofelone can be used for the research of inflammatory bowel disease[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C18H27NO2S |
|---|---|
| Molecular Weight | 321.47700 |
| Exact Mass | 321.17600 |
| PSA | 74.63000 |
| LogP | 4.04760 |
| 5-[(3,5-di-tert-butyl-4-hydroxyphenyl)methyl]-1,3-thiazolidin-4-one |
| 5-(3,5-Di-tert-butyl-4-hydroxy-benzyl)-thiazolidin-4-one |
| Tazofelone |
| 5-{[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl}-4-thiazolidinone |
| 2,6-di-tert-butyl-4-(1,3-thiazolidin-5-ylmethyl)phenol |
| LY213829 |
| 4-thiazolidinone-5-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl |